Status:
COMPLETED
Improving Postural Control Through Innovative Stimulation of the Proprioceptive System
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Sensorimotor Disorder
Eligibility:
All Genders
7+ years
Phase:
NA
Brief Summary
Every movement humans make in everyday life is based on a continuous integration of sensory information. A good interaction between sensory processes and motor control, called sensorimotor integration...
Detailed Description
This is particularly important when considering populations with impaired proprioception resulting in impaired posture and gait control. This is particularly the case for older adults and children wit...
Eligibility Criteria
Inclusion
- Older Adults:
- Affiliated or beneficiaries of a social security plan
- Who have freely given their written consent after having been informed of the purpose, the procedure and the potential risks involved
- Children with Cerebral Palsy:
- Children between the ages of 7 and 18 years, diagnosed with Spastic Cerebral Palsy, presenting with a clinical picture of infantile cerebral hemiplegia or diplegia.
- Children able to understand and follow the simple instructions of the examination
- Children walking GMFCS (Gross Motor Functional Classification system) I to II.
- Children with at least one parent and the child having given and signed the consent agreement
- Children who are members or beneficiaries of a social security system
Exclusion
- Older adults:
- Pathology or surgery resulting in a locomotor disorder, within 6 months prior to the study,
- Chronic neurological, motor or psychological pathologies
- Use of neuro-active substances likely to alter cortico-spinal excitability (hypnotics, anti-epileptics, psychotropic drugs, muscle relaxants) during the study.
- Contraindication to transcranial magnetic stimulation:
- Cardiac or respiratory insufficiency.
- Wearing a cardiac pace maker.
- Wearing a heart valve and severe cardiovascular diseases.
- Presence of prosthetic material or ferromagnetic foreign bodies in the head.
- Presence of cochlear implants or ocular prosthetic material.
- History of neurosurgical procedures.
- Neurological diseases that may affect brain structures and cognitive abilities (e.g., intracranial tumor, multiple sclerosis, history of stroke or head injury).
- Participation at the same time in another interventional trial or having participated in a such a study within 30 days prior to this study.
- Obesity (body mass index ≥ 30.0 kg/m²)
- Children with cerebral palsy:
- Children with concomitant muscle disease (e.g., myopathy...).
- Children who have received a baclofen injection in the 6 months preceding the evaluation.
- Children who have undergone neuro-orthopedic surgery on the lower limbs within the last 6 months
- Children who have received a botulinum toxin injection within the last 6 months
- Children participating in therapeutic programs other than their usual physical therapy sessions.
Key Trial Info
Start Date :
June 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 22 2024
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT05367791
Start Date
June 29 2022
End Date
July 22 2024
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Saint-Etienne
Saint-Etienne, France, 42055